Next Article in Journal
Perfluoroalkylated Substances (PFAS) Associated with Microplastics in a Lake Environment
Next Article in Special Issue
Effects of Polydopamine Microspheres Loaded with Silver Nanoparticles on Lolium multiflorum: Bigger Size, Less Toxic
Previous Article in Journal
Assessing Combined Effects for Mixtures of Similar and Dissimilar Acting Neuroactive Substances on Zebrafish Embryo Movement
Previous Article in Special Issue
Disturbance in Mammalian Cognition Caused by Accumulation of Silver in Brain
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

In-Vitro and In-Vivo Tolerance and Therapeutic Investigations of Phyto-Fabricated Iron Oxide Nanoparticles against Selected Pathogens

1
Department of Microbiology, Hazara University, Mansehra 21300, Pakistan
2
Department of Biology, College of Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia
3
Department of Pharmacy, Abbottabad Campus, COMSATS University Islamabad, Islamabad 22060, Pakistan
4
Department of Chemistry, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia
5
Department of Chemistry, University of Azad Jammu and Kashmir, Muzffarabad 13100, Pakistan
*
Author to whom correspondence should be addressed.
Toxics 2021, 9(5), 105; https://doi.org/10.3390/toxics9050105
Submission received: 16 March 2021 / Revised: 27 April 2021 / Accepted: 3 May 2021 / Published: 8 May 2021
(This article belongs to the Collection Environmental and Health Risks of Nanotechnology)

Abstract

:
The Paeonia emodi (P. emodi)-mediated iron oxide nanoparticles (Fe2O3 NPs) were screened for in-vitro and in-vivo antibacterial activity against the Staphylococcus aureus (S. aureus) (ATCC #: 6538) and Escherichia coli (E. coli) (ATCC #:15224). The synthesized Fe2O3 NPs were characterized via nitrogen adsorption-desorption process, X-ray diffractometer (XRD), transmission and scanning electron microscopies (TEM and SEM), energy dispersive X-ray (EDX) and Fourier transform infrared (FTIR) spectroscopies. The SBET was found to be 94.65 m2/g with pore size of 2.99 nm, whereas the average crystallite and particles size are 23 and 27.64 nm, respectively. The 4 μg/mL is the MIC that inhibits the growth of E. coli, whereas those for S. aureus are below the detection limit (<1.76 μg/mL). The tolerance limit of the mice model was inspected by injecting different concentration of Fe2O3 NPs and bacteria suspensions. The 14 ppm suspension was the tolerated dose and the concentration above were proved lethal. The most severe infection was induced in mice with injection of 3 × 107 CFUs of both bacteria, while the inoculation of higher concentrations of bacterial suspensions resulted in the mice’s death. The histopathological and hematological studies reveals that the no/negligible infection was found in the mice exposed to the simultaneous inoculation of Fe2O3 NPs (14 ppm) and bacterial suspensions (3 × 107 CFUs).

Graphical Abstract

1. Introduction

The high frequency of bacterial infection and the developing of drug-resistant strain against the common used antibiotic is a grand change all over the world [1]. It is critical to fight against bacterial infections with conventional antibiotic therapy and thus the increasing number of resistant microbes a serious health problem [2]. Therefore, new methods and novel antimicrobial agents are needed for the treatment of incurable microbial infections to secure health around the globe [3]. The recent development in nanotechnology have enable the researchers to treat microbial infections using atomic scale particles. These extremely small particles possess high antibacterial potential to kill or reduce the bacterial colonies, provide larger surface to contact with disease causing microbes. The nanomaterials are extensively used for biomedical applications (i.e., nano-medicines, food preservation, wound dressing, protective clothing, disinfection, drug delivery and antimicrobial agents) [4]. Due to low cytotoxicity and high potency, nanoparticles are an attractive alternate of the conventional antibiotic and emerge as a new generation antibiotic [5].
The iron oxide nanoparticles are reported to have applications in targeted drug delivery, lithium ion batteries, magnetic resonance imaging (MRI), targeted destruction of tumor tissue through hyperthermia and removal of toxic metals from contaminated water [6,7,8,9]. The Fe2O3 NPs adversely affect the soil enzymatic activities of urease, catalase, phosphatase and also affect the microbial communities in a negative way. These metal oxides also exert growth inhibitory effect on the strains of Gram-negative and Gram-positive bacteria. It has also been explained in the literature that these metal oxides reduce the chlorophyll content and carotenoids along with the reduction in the length of root and shoot of rice [10]. Fe2O3 NPs can induce oxidative stress, protein aggregation and the iron accumulation and these oxide NPs can also induce neurodegeneration by inducing apoptosis [11]. Fe2O3 NPs have a moderate cytotoxic effect on lungs and can cause interstitial inflammation in lungs after pulmonary fibrosis [12]. Some of the studies have shown that the Fe2O3 NPs are converted to free iron ions after metabolism in the cells by lysosomes that affect most of the biological processes. These free ions can directly damage the mitochondria and increase the radical concentration. Another toxic effect of the Fe2O3 NPs include the significant DNA damage, along with the decreased capacity of the cells to repair DNA lesions [13]. The Fe2O3 NPs have been synthesized via sol-gel, hydrothermal, solvothermal, sonochemical, microemulsion, co-precipitation and green methods [14,15]. Among the green processes, plant mediated synthesis is a subject of great attention due to the easy handling, low cost, high yield and minimum time consumptions. Many researchers have studied in-vitro antimicrobial activity; however, very limited literature are available on in-vivo therapeutic property of Fe2O3 NPs on an animal model. Thus, a detailed study required to explore systematic toxicity and in-vivo therapeutic efficacy of Fe2O3 NPs against disease causing pathogens.
In current study, P. emodi leaves extract was used as reducing and capping agent for the green synthesis of Fe2O3 NPs. The P. emodi belongs to the family Paeoniaceae found in the hilly area of northern area of Pakistan and locally used for the treatment of colic, asthma and hypertension. The physiochemical properties of the synthesized Fe2O3 NPs were investigated through N2 adsorption-desorption, XRD, SEM, TEM, FTIR and EDX techniques. The MIC and in-vitro experiment was performed using the 96-well plate and agar well diffusion methods respectively. The in-vivo tolerance of the mice model was examined by inoculation of different concentrations of the selected bacteria and Fe2O3 NPs. The synergistic effect of bacteria and Fe2O3 NPs on the mice model was also observed by execution of histopathological and hematological analysis.

2. Materials and Methods

2.1. Chemical Used

The analytical grade chemicals, including iron sulphate heptahydrates, iodonitrotetrazolium chloride ethanol and agar nutrients, were purchased from Sigma-Aldrich. All the working solutions were prepared in deionized water whereas the Fe2O3 NPs suspensions for in-vitro and in-vivo were prepared in normal saline. The glassware were washed with 15 % (v:v) nitric acid solution and rinsed with deionized water. The selected bacterial pathogens were obtained from the department of Pharmacy.

2.2. Preparation of P. emodi Leaves Extract

The collected healthy P. emodi leaves were washed with ordinary water, followed by deionized water, in order to remove dust particles. The leaves were shade dried to avoid any damage to chlorophyll and other chemical constituents. The leaves were then chopped into fine pieces with a sterile chopper and 10 g of the chopped leaves was added into a titration flask containing 200 mL of boiled deionized water. The titration flask was tightly covered with aluminum foil for 12 h. The light-green crude mixture was filtered and centrifuged (at 4000 for 15 min) and the clear upper layer was stored at 4 °C.

2.3. Synthesis of Fe2O3 NPs

For the synthesis of Fe2O3 NPs, a stock solution (5 mM) was prepared by dissolving 0.72 g in 0.5 L of deionized water. For each reaction, 15 mL of the extract was slowly added into 45 mL of precursor solution with constant stirring at 50 °C. After 60 min, the reaction mixture was aged for 24 h at room temperature and the suspended particles were collected via centrifugation. The solid product obtained was washed with deionized water followed by ethanol and were dried at 100 °C and stored in an airtight polyethylene bottle.

2.4. Characterization

The GeminiVII2390i instrument was run to perform the N2 adsorption-desorption experiment and the data obtained were manipulated by BET and BJH methods to deduced texture parameters (surface area and pore size). The Panalytical X-pert Pro was operated in the 2θ range of 20°–80° to determine the crystallographic parameters, whereas the full width and half maxima (FHWM) values were considered to calculate crystallite size. The surface morphology was studied via SEM model 5910, JEOL, Tokyo, Japan and TEM (HRTEM, JEM-2010) provided by Field Electron and Ion Company (FEI), Cleveland, TN, USA. The EDX coupled with SEM (model: INCA 200, Oxford Instruments, Oxfordshire, UK) was used to analyze the elemental composition, whereas the surface chemical moieties were identified via FTIR analysis (Nicolet 6700, Thermo Fisher Scientific, Waltham, MA, USA).

2.5. Minimum Inhibitory Concentration Assay

The minimum inhibitory concentration (MIC) experiment was carried via the 96-well plate method, also called ELISA, and 100 μL of broth media was transferred to 72 wells of column 1 to 9. The 100 μL of Fe2O3 NPs (1024 μg/mL) in triplicate in 48 wells (column 1 to 6), whereas the antibiotic solution (256 μL/mL) was poured into 24 wells (column 10 to 12) in triplicate. The dilution was done by taking 100 μL from the first row and added into the second row and so on, whereas the 100 μL taken from the last row was discarded. The microbial suspension E. coli and S. aureus in normal saline and compared with 0.5 MacFarland standard and the 100 μL bacterial suspension. The S. aureus suspension was added in the first three columns, whereas the next column was loaded with E. coli suspension. The 40 μL iodonitrotetrazolium chloride (INT) solution (1 mg/5 mL) was added into the columns containing bacteria suspension, which act as indicator for the non-inhibitory concentration of Fe2O3 suspension. Then, after the addition of 40 μL of INT solution and 100 μL bacterial suspension, the final concentration of the stock suspension was reduced to 898.25 μL/mL from 1024 μg/mL. The MIC value was counted at the lowest concentration in the row just before the row where the color change occurred. The ciprofloxacin was used as the positive control to compare the activity/efficacy of Fe2O3 NPs.

2.6. In-Vitro Antibacterial Assay

The agar well diffusion method was used to examine the in-vitro antibacterial efficacy of Fe2O3 NPs against the E. coli (ATCC #:15224) and S. aureus (ATCC #: 6538), where agar nutrient was used as medium for antibacterial susceptibility test. The 0.5 McFarland solution was used for clinical strain where Fe2O3 stock suspension was prepared by dispersing 1, 2, 3 and 4 mg in 1 mL in normal saline. The wells with diameter of 8 mm were bored with sterile borer and bacterial pathogen was streaked on media with help of sterile swabs. Afterward, 100 μL of each suspension was added into each well independently and were incubated at 37 °C. The zone of inhibition was measured in millimeter (mm) after 24 h was consider is the activity of Fe2O3 NPs against selected bacteria.

2.7. Tolerance Study

All animal experiments were performed in compliance with the local ethics committee. The female mice that were aged between 6 to 8 weeks and weighed 20–22 g were randomly divided into five groups (n = 5 for each group). Effect of Fe2O3 NPs concentration on the mice model was examined by injecting 0.066 mL of 5, 10, 15, 20 and 25 ppm suspension into five mice groups (n= 5 for each group) and their behavior observed for 14 days. Similarly, to test the tolerance of mice against bacterial pathogens, five groups of mice (n = 5) were individually inoculated with different suspensions (1 × 107, 2 × 107, 3 × 107, 4 × 107 and 5 × 107 CFUs) of both pathogens and examined for fourteen days. Initially, the behavior of the mice model was examined for four hours, after which it was checked every 8 h for 14 days, to see any unusual behaviors, eating, drinking and weight. The maximum dose of nanoparticles and the bacterium suspension on which mice survive for 14 days were utilized for further studies.

2.8. In-Vivo Antibacterial Study

The in-vivo therapeutic activity of Fe2O3 NPs against S. aureus and E. coli was evaluated upon the simultaneous inoculation of 14 ppm and 3 × 107 CFUs suspensions of Fe2O3 NPs and bacterial pathogens. The histopathological examination of kidney, spleen, lung and liver was performed after the simultaneous inoculation of Fe2O3 NPs and pathogen suspension. The healthy and pathogen-free mice that had an age between 6 to 8 weeks and weighed 20–22 g were selected for in-vivo antibacterial studies. A 0.066 mL of Fe2O3 NPs suspension (14 ppm) and bacterial suspensions (3 × 107 CFUs) were administered simultaneously into the mice model. The efficacy of Fe2O3 NPs were examined by comparing the histopathological and hematological results of infected mice with those inoculated with both bacteria and Fe2O3 NPs at the same time.

2.9. Histopathological Study

The kidney, spleen, liver and lung were chosen for the histopathological study and a small portion of these organs were treated with 10% formalin followed by the paraffin, and cut down into 5–6 mm (mm) slices and fixed on the glass microscopic slide utilizing the standard histopathological process [12]. The hematoxylin eosin was used to stain the sections and examined through light microscope.

2.10. Hematological Assay

The blood sample taken from the heart of mice infected with bacterial species and those injected with the specific amount of both Fe2O3 NPs and bacteria suspensions were measured after anticoagulation. The automatic hematology analyzer (MEK-6318K) was used to study the blood parameters like red blood cell (RBC), red blood cell volume distribution width (RDW), white blood cell (WBC), hemoglobin (HGB), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), platelet count (PLT), mean platelet volume (MPV), mononuclear percentage (MOD%), lymphocyte percentage (LYM%) and granulocyte percentage (GRN%).

3. Results

3.1. Physicochemical Study

3.1.1. Surface Area and XRD Analysis

The reversible type II N2 adsorption/desorption isotherm obtained for Fe2O3 NPs shows maximum adsorption in the range of 0.75 to 9.8 p/po, forming the H3 hysteresis loop. Usually this type of isotherm is obtained for the aggregates of plate-like particles. The surface area calculated by BET method is 94. 65 m2/g, whereas the BJH pore size along with pore volume are found to be 2.99 nm and 0.443 cc/g, respectively. The XRD technique was employed to find out the structural properties of Fe2O3 NPs (inset: Figure 1). The X-ray diffraction pattern confirmed the crystalline nature of Fe2O3 NPs as sharp diffraction peaks were observed. The diffraction peaks for Fe2O3 NPs at 2θ position are 30.34°, 35.71°, 43.32°, 53.98°, 62.88° and 74.29° and correspond to the hkl values of (220), (110), (202), (112) and (214), respectively. All these diffraction peaks are matching with the standard reference card 01-071-6336 and are associated with Fe2O3 NPs with face-centered cubic geometry. The average crystallite size estimated by Scherer’s formula is 23 nm.

3.1.2. SEM and TEM Analysis

The SEM and TEM techniques are operated to analyze the surface features of Fe2O3 NPs as shown in Figure 2a,b. The SEM image Figure 2a reveals that the agglomeration of small particles led to the formation of bunch like structure. However, due to the aggregation of small particles, it is difficult to identify the specific shape and size of particles from SEM micrograph. The TEM micrograph (Figure 2b) explains the physical appearance of Fe2O3 NPs, where the majority of the particles exhibit a spherical/nearly spherical shape with an almost smooth surface. The mono-disperse particles are interconnected with each other led to the formation of a larger network of small particles. The particles with clear boundaries are considered to estimate the particles size and are found in the range of 22.05 to 34.26 nm with an average size of 27.64 nm.

3.1.3. FTIR and EDX Analysis

The FTIR spectrum of Fe2O3 NPs, shown in Figure 3, possess a broad absorption band at 3000–3500 cm−1 and a weak band at 1200 cm−1, which are associated to the stretching vibration of hydroxyl groups [13]. A weak vibration at 570 cm−1 as well as a small band at 800 cm−1 can be assigned to the bending vibration of iron and oxygen in Fe2O3 NPs [10]. The EDX of Fe2O3 NPs (inset: Figure 3) exhibit sharp characteristic peaks at 0.8, 6.4 and 7.1 keV, attributed to the presence of iron along an intense peak at 0.5 keV due to oxygen. The data reveals that Fe2O3 NPs contain a 61.68% weight of iron with a 38.32% weight of oxygen. The purity of Fe2O3 NPs can; therefore, be claimed as only the peaks associated to iron and oxygen were detected.

3.2. In-Vitro Therapeutic Study

3.2.1. Minimum Inhibitory Concentration

The quantitative estimate of Fe2O3 NPs for antibacterial activity was evaluated by performing minimum inhibitory concentration (MIC) analysis against the selected pathogen as shown in Figure 4. The colorless wells shows that the amount of Fe2O3 NPs was capable to inhibit bacterial growth where color wells indicate the inhibition was unsuccessful. The concentration in the colorless well just before the colored wells is count as MIC against that organism. The color change in the well containing 1.76 μg/mL shows that the 3.51 μg/mL of Fe2O3 NPs was the minimum amount that inhibit the growth of E. coli. The last wells were not turn colored suggest that the MIC of Fe2O3 NPs against S. aureus is the detection limit (<1.76 μg/mL). The results shows the concentration dependent activity against selected pathogens and suggest that Fe2O3 NPs have strong inhibiting power against S. aureus as compared E. coli.

3.2.2. In-Vitro Antibacterial Activity

The Fe2O3 NPs was screened against S. aureus and E. coli following agar well diffusion process and the clear inhibition zones was measured is the activity synthesized materials. The experimental photographs given in Figure 5, shows that with increasing concentration of Fe2O3 NPs suspension, the growth inhibiting capability also increases. Previously the dose dependent antibacterial activity of Fe2O3 NPs was conducted, where the zone of inhibition for S. aureus was 7 mm at 5 mg/mL, but it nearly doubled to 12.5 mm at 30 mg/mL. Klebsiella spp., on the other hand, is tolerable at doses between 5 and 20 mg/mL, although 30 mg/mL doses result in an inhibition zone of around 9 mm [16]. Base on the inhibition zones, it was seen that S. aureus shows less resistance to Fe2O3 NPs as compared to E. coli. This was also proven in the MIC experiment that the growth of S. aureus bacteria was inhibits lower Fe2O3 NPs concentration (<1.76 μg/mL), whereas 3.51 μg/mL was required to stop growth of E. coli. Cell wall composition, surface charge, rigidity and permeability are the key factors that affect the activity of any antibacterial agent [3]. The phosphate group of teichoic acid exist in cell wall of Gram-positive bacteria, whereas phospholipids and lipopolysaccharide present in the cell wall of Gram-negative bacteria are responsible for surface negative charge [2].
Several reactive species present in the aqueous suspension of Fe2O3 NPs, including metal cation, hydroxyl radical and superoxide radical anion contributing to the antibacterial action of MO NPs. The Fe2O3 NPs have the ability to produce the iron cation (Fe3+) in solution, which accumulated on the surface of bacteria due to the electrostatic forces of attraction. The Fe3+ cation penetrates inside to disturb the cytoplasmic composition and inhibit the growth of microorganisms [4]. The antimicrobial action of Fe2O3 NPs is also because of hydroxyl radical and superoxide present in the solution. The dissolved oxygen is a major source for the production of superoxide radical, which reacts with polyunsaturated compounds of the outer membrane, causing a significant damage to the cell by initiating self-propagation chain reactions. The hydroxyl radical is an aggressive oxidant and denature several biological molecules present in the microorganisms [14]. The reaction of water and hydroxyl radical led to the production of hydrogen peroxide, which penetrate inside the bacterium cell and disturb the cytoplasmic composition and prove lethal for microbial life [15].

3.3. Tolerance and Therapeutic Study

3.3.1. Histopathological Analysis

Effect of Fe2O3 NPs concentration on mice model was examined by injecting 5, 10, 15, 20 and 25 ppm into five mice groups (n = 5 for each group) and observed their behavior for 14 days. The mice inoculated with 20 and 25 ppm are either expired on the spot or with passage of time, whereas those exposed to 10 ppm live for 14 days. Extreme skin infection was examined in mice feed with 15 ppm suspension. The mice were seemingly disturbed and gradual weight loss was observed, which may be due to the decreased appetite. The strange behavior of mice continued till day 14, whereas two members of this group died after 11 days. This shows that the concentration above 15 ppm was not significant under the current reaction condition. Afterward, four groups of mice were inoculated with 11, 12, 13, 14 ppm to find the exact tolerated dose of Fe2O3 NPs. The mice in the groups injected with 11 and 12 ppm were normal till day 14, took normal food and performed usual activities. The mice dosed with 14 ppm suspension lived till day 14; however, skin infection increased and minor weight loss was observed up to day nine. Later on, the mice used took normal food and lead a normal life with no unusual behavior. The control group, tolerated group (14 ppm; where the infected mice become normal after few days) and the high dose group (20 ppm; lethal dose led to death) were subjected to histopathological examination to evaluate the effect of Fe2O3 NPs on the different organs of mice. The results, shown in Figure 6, reveal the comparative histopathological observation of the kidney, spleen, lung and liver of the mice.
The kidney section, shown in Figure 6, aside from a mild congestion, showed no major difference between the control group and those exposed to the tolerated dose. The kidney of mice inoculated with the lethal dose shows lesions with a different degree of hemorrhages and necrotic foci due to the ischemic and nephrotoxic agent. The degenerative changes in tubular epithelial cells were observed with frequent leukocytic infiltrations. The metabolic irregularity in mice was due to the necrosis in the tubular epithelium [16,17,18]. The histopathological study shows that the spleen seemed normal after 14 days post injection of the tolerated dose, and a minor hemorrhage was observed in the parenchyma of spleen. The extensive leukocyte infiltration was seen in the splenic parenchyma of mice inoculated with the lethal dose, whereas crippled blood vessels were seen in both spleen sections. The slight inflammation with broadened alveolar septum and a rounded shaped bronchiole was observed in the lung of mice injected with 14 ppm suspension of Fe2O3 NPs. The coagulation in the epithelial linings with complete damage of bronchi, leading to extensive leukocytic infiltration, was observed in the lung section of mice inoculated with 20 ppm Fe2O3 suspension [18,19]. The few alveoli filled with fibrin were ruptured and coalesced together to form a bullae [20]. Chronic inflammation in the alveolar septum was seen, leading to pathological lesion and, ultimately, resulting in complete damage [21]. Beside the minor congestion and hemorrhages, the hepatocytes are seen to be normal in the liver section at low dose. Extensive lesions with moderate hemorrhaging were found in the liver after dosing with 20 ppm suspension of Fe2O3 NPs [18,22].
To observe the tolerance of mice against bacterial pathogens, five groups of mice (n = 5) were individually inoculated with different suspensions (1 × 107, 2 × 107, 3 × 107, 4 × 107 and 5 × 107 CFUs) of S. aureus and examined for fourteen days. The histopathological examination of the kidney, spleen, lung and liver was carried out for two groups—the group injected with 3 × 107 CFUs (tolerated dose) and the group injected with 4 × 107 CFUs (lethal dose)—and the microscopic results are shown in Figure 7. The same experiment was repeated to examine the tolerance of mice against E. coli and the microscopic images are given in Figure 8. The mice loaded with lethal dose died with the passage of time and showed sudden weight losses, unusual behavior and extreme skin infections. The mice administered with 3 × 107 CFUs showed minor skin infection, dehydration and weight loss, a low intake of food and uncontrolled breathing with unusual behavior.
The kidney of mice injected with a tolerated dose of both bacterial suspensions showed mild congestion and necrosis on the parenchymal surface, whereas degeneration in the glomeruli and extensive necrosis with a high degree of infiltrations were seen in mice exposed to the lethal dose. The spleen of mice exposed to S. aureus (3 × 107 CFUs) was almost normal, whereas mild hemorrhaging was found in the spleen of mice injected with 3 × 107 CFUs of E. coli. Extreme leukocytic infiltration in the parenchyma and hemorrhaging on the capsular spleen surface were seen after the inoculation of 4 × 107 CFUs of both bacteria. In lung cells, a slightly broadened alveolar septum and lymphocyte infiltration were seen at low dose, whereas, at high dose, extensive widening and huge lymphocyte penetration resulted in the complete damage of lung cells [23]. The tissue of the studied organs of the mice administered with the tolerated dose were found to be normal/nearly normal in comparison with the control group. The histopathological observation discloses the extreme abnormal condition of mice organs exposed to the lethal/high concentration of Fe2O3 NPs and bacterial inoculums.
The in-vivo therapeutic activity of Fe2O3 NPs against S. aureus and E. coli was evaluated upon the simultaneous inoculation of 14 ppm and 3 × 107 CFUs suspensions of Fe2O3 NPs and bacterial pathogens (Figure 9). The histopathological examination of the kidney, spleen, lung and liver was performed after the simultaneous inoculation of Fe2O3 NPs (14 ppm) and bacterial pathogens (3 × 107 CFUs) as shown in Figure 8. After the vaccination of Fe2O3 NPs and bacterial suspension at the same time, the mice were seemingly disturbed and had no attraction for food for a few days. The mice became normal with the passage time and took normal food. The therapeutic results reveal that the severe infections that were experienced during the tolerance study of mice against bacteria were not observed. However mild changes were experienced during the histopathological observations. An insignificant congestion and hemorrhaging with no morphological symptoms were seen in the kidney and liver of mice exposed to S. aureus and Fe2O3 NPs at the same time, respectively. The histopathology also suggests that minor changes were found in the mice exposed to E. coli and Fe2O3 NPs. A mild congestion in the kidney along with insignificant hemorrhaging in the liver were observed. A slightly suppressed respiratory bronchiole with alveoli appeared in the lung section, whereas the liver section was almost normal.

3.3.2. Hematological Analysis

The hematological study was conducted for the mice infected with bacteria and those inoculated with bacteria and Fe2O3 NPs at the same time. The blood samples taken from the heart of mice were measured after anticoagulation. The blood parameters, like WBC, RBC, HGB, MCV, MCH, MCHC, RDW, PLT, MPV, LYM%, MOD%, GRN%, were determined by an automatic hematology analyzer (MEK-6318K). The blood hematological study reveals several significant changes for the mice exposed to both Fe2O3 NPs and pathogenic suspension. Compared with normal values, some blood parameters, including WBC, MON#, GRAN#, Lymph, MON%, GRAN%, RDW and PLT, of the infected mice were significantly high, whereas a valuable decrease was seen in MCV, MCH and MCHC as compared to the normal values, as shown in Table 1. The nanoparticles are believed to enter into the lungs and, by breaking the alveolar cell, were transferred into the blood circulating system and disturbed the hematological system [19,24].
The high count of WBC (leukocytosis) is a sign of emotional and physical stress and shows that the immune system is working against an infection. It is also reported that the organism with particular blood cancer may also have a high WBS count. The idiopathic hyper eosinophilic syndrome can cause damage to the heart, liver, lungs, skin and nervous system and the organism may experience weight loss, swelling, skin rash, confusion, weakness and coma [25]. The severe infections are responsible for monocytosis, which is a common sign of chronic myelomonocytic leukemia, where the blood is produced in the bone marrow. However some recent investigations reveal that the higher monocyte number is related to some cardiovascular diseases [18,26]. Granulocytes are WBCs that possess small granules which help to fight against viral and bacterial infection. The number of granulocytes (granulocytosis) increases for infections, autoimmune diseases and blood cell cancer and the organism experiences abnormal breeding, pale skin, excessive sweating during sleeping, fatigue and loss of appetite [27].
The amount of red blood cells (RBCs) can be measured via the red blood distribution width (RDW) blood test, and the RDW score above the normal range is due to nutrient deficiency (iron, vitamin B-12 and folate) and infections, and can also be linked to anemia, cancer, heart and liver diseases [19]. High RDW with low MCV indicates microcytic anemia related to the deficiency of RBCs and will be smaller than the normal value [21]. The Alanine aminotransferase (ALT) is released into the blood stream due to the damage of the liver cell and the organism may experience jaundice, loss of appetite, tiredness, abdominal pain, nausea and vomiting. The high ALT indicates liver damage due to hepatitis, liver cancer, cirrhosis and the intake of medicines that cause liver infections [28]. The hematocrit test (HCT) is carried out to estimate the proportion of RBCs in the body, and higher values are because of dehydration, polycythemia and lung/heart disorders. The mean MCV, which is the average RBCs’ size, and the range of MCV shows the type of anemia that the organism experienced. The microcytic anemia is the lower MCV, where the RBCs’ sizes are too small, which are due to lead poisoning, chronic disease, thalassemia and iron deficiency (poor dietary intake of iron, menstrual/ gastrointestinal bleeding) [29]. The mean MCH is the average quantity of hemoglobin in RBCs in the body. The microcytic anemia, celiac disease and iron deficiency are the main causes of the low MCH and symptoms like shortness of breath, loss of regular stamina, dizziness, regular tiredness, weakness in the body and some skin infections may also appeared, when the MCH levels fall too low [30]. The mean MCHC is the normal concentration of hemoglobin inside a single RBC. The organism with low MCHC levels may have fatigue, shortness of breath, pale skin, easily bruised, dizziness and weakness. The most common cause of low MCHC is hypochromic microcytic anemia, which is due to the lack of iron, hemolysis and peptic ulcer. The organism with this type anemia experience rapid breathing, fast heart rate, sweating, confusion, coughing, wheezing and shortness of breath [31]. All these observations suggest that the infection was caused in mice due to insertion of bacterial pathogens. Thus, an attempt was made to examine the in-vivo therapeutic effect of Fe2O3 NPs against bacterial infections, and the data obtained from the hematological analysis of the blood samples from the extremely infected mice (no death) treated with Fe2O3 NPs. The results show that the increased/decreased values of WBC, MON#, Lymph, MON% and MCV were found almost in the normal range, which confirm the therapeutic significance of Fe2O3 NPs. The deviated values of GRAN%, PLT, RDW, MCH and MCHC tended toward the normal range after the simultaneous inoculation of Fe2O3 NPs and bacterial pathogens. All these results prove the in-vivo therapeutic efficacy of Fe2O3 NPs against S. aureus and E. coli in a mouse model.

4. Conclusions

An easy and eco-friendly attempt was made for the synthesis of Fe2O3 NPs and the highly crystalline nature and nano-range particles was confirmed through different physicochemical techniques. The MIC concentration for S. aureus was found to be less than 1.76 mg/L, whereas that for E. coli was 3.51 mg/L. The in-vitro study shows that E. coli shows greater resistance against the Fe2O3 NPs, as compared to S. aureus. The in-vivo tolerance study shows that the mice sustain up to 14 ppm suspension of Fe2O3 NPs and 3 × 107 CUFs of bacteria, whereas the higher concentration induced extreme histological lesion, congestion, hemorrhaging and complete damage of bronchi, which, ultimately, led to the death of the mice. The deviated values of some blood parameters confirm the infection was caused due to the inoculation of bacteria. However, the histopathological and hematological investigations reveals that no/negligible infection was found in the mice after simultaneous injection of Fe2O3 NPs and bacterial suspension. Thus, this study explores the therapeutic significance of Fe2O3 NPs and reveals that, up to a specific concentration, Fe2O3 NPs could be an excellent candidate for both in-vitro and in-vivo antibacterial activity.

Author Contributions

Conceptualization, I.T., S.K.H. and M.A.Y.; methodology, A.S., I.T., M.A.Y., S.K.H.; software, S.H.; validation M.B.A., A.M. and A.H.; formal analysis, A.S., S.H.; investigation, A.S.; resources, I.T. and M.A.Y.; data curation, A.S., S.H.; writing—original draft preparation, A.S., S.H.; writing—review and editing, M.B.A., A.M. and A.H.; visualization, S.H., A.S.; supervision, I.T. and M.A.Y.; project administration, M.B.A., A.M. and A.H.; funding acquisition, M.B.A., A.M. and A.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Deanship of Scientific Research for funding this article by Taif University Researchers Supporting Project number (TURSP-2020/28), Taif University, Taif, Saudi Arabia.

Institutional Review Board Statement

The study was conducted according to the guidelines approved by the Institutional Review Board (or Ethics Committee) of department of microbiology, Hazara University, Mansehra.

Informed Consent Statement

Not applicable.

Acknowledgments

The authors are grateful to the Deanship of Scientific Research for funding this article by Taif University Researchers Supporting Project number (TURSP-2020/28), Taif University, Taif, Saudi Arabia.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zare, E.; Pourseyedi, S.; Khatami, M.; Darezereshki, E. Simple biosynthesis of zinc oxide nanoparticles using nature’s source, and it’s in vitro bio-activity. J. Mol. Struct. 2017, 1146, 96–103. [Google Scholar] [CrossRef]
  2. Haq, S.; Rehman, W.; Waseem, M.; Meynen, V.; Awan, S.U.; Saeed, S.; Iqbal, N. Fabrication of pure and moxifloxacin functionalized silver oxide nanoparticles for photocatalytic and antimicrobial activity. J. Photochem. Photobiol. B Biol. 2018, 186, 116–124. [Google Scholar] [CrossRef] [PubMed]
  3. Haq, S.; Rehman, W.; Waseem, M.; Shah, A.; Khan, A.R. Green synthesis and characterization of tin dioxide nanoparticles for photocatalytic and antimicrobial studies. Mater. Res. Express 2020, 7, 1–9. [Google Scholar] [CrossRef]
  4. Shah, A.; Haq, S.; Rehman, W.; Waseem, M.; Shoukat, S.; Rehman, M.U. Photocatalytic and antibacterial activities of paeonia emodi mediated silver oxide nanoparticles. Mater. Res. Express 2019, 6, 1–8. [Google Scholar] [CrossRef]
  5. Bhattacharya, R.; Mukherjee, P. Biological properties of “naked” metal nanoparticles. Adv. Drug Deliv. Rev. 2008, 60, 1289–1306. [Google Scholar] [CrossRef] [PubMed]
  6. Parveen, S.; Misra, R.; Sahoo, S.K. Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed. Nanotechnol. Biol. Med. 2012, 8, 147–166. [Google Scholar] [CrossRef]
  7. Iv, M.; Telischak, N.; Feng, D.; Holdsworth, S.; Yeom, K.; Daldrup-Link, H. Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors. Nanomedicine 2015, 10, 993–1018. [Google Scholar] [CrossRef]
  8. Espinosa, A.; Di Corato, R.; Kolosnjaj-Tabi, J.; Flaud, P.; Pellegrino, T.; Wilhelm, C. Duality of Iron Oxide Nanoparticles in Cancer Therapy: Amplification of Heating Efficiency by Magnetic Hyperthermia and Photothermal Bimodal Treatment. ACS Nano 2016, 10, 2436–2446. [Google Scholar] [CrossRef]
  9. Alexiou, C.; Schmid, R.J.; Jurgons, R.; Kremer, M.; Wanner, G.; Bergemann, C.; Huenges, E.; Nawroth, T.; Arnold, W.; Parak, F.G. Targeting cancer cells: Magnetic nanoparticles as drug carriers. Eur. Biophys. J. 2006, 35, 446–450. [Google Scholar] [CrossRef]
  10. Kamran, M.; Ali, H.; Saeed, M.F.; Bakhat, H.F.; Hassan, Z.; Tahir, M.; Abbas, G.; Naeem, M.A.; Rashid, M.I.; Shah, G.M. Unraveling the toxic effects of iron oxide nanoparticles on nitrogen cycling through manure-soil-plant continuum. Ecotoxicol. Environ. Saf. 2020, 205, 111099. [Google Scholar] [CrossRef]
  11. Yarjanli, Z.; Ghaedi, K.; Esmaeili, A.; Rahgozar, S.; Zarrabi, A. Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci. 2017, 18, 1–12. [Google Scholar] [CrossRef] [Green Version]
  12. Szalay, B.; Tátrai, E. Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments. J. Appl. Toxicol. 2012, 446–453. [Google Scholar] [CrossRef]
  13. Askri, D.; Cunin, V.; Béal, D.; Berthier, S.; Chovelon, B.; Arnaud, J.; Rachidi, W.; Sakly, M.; Amara, S.; Sève, M.; et al. Investigating the toxic effects induced by iron oxide nanoparticles on neuroblastoma cell line: An integrative study combining cytotoxic, genotoxic and proteomic tools. Nanotoxicology 2019, 13, 1021–1040. [Google Scholar] [CrossRef] [PubMed]
  14. Ahmad, S.; Farrukh, M.A.; Khan, M.; Khaleeq-ur-, M.; Tahir, M.A. Synthesis of Iron Oxide–Tin Oxide Nanoparticles and Evaluation of their Activities against Different Bacterial Strains. Can. Chem. Trans. 2014, 2, 122–133. [Google Scholar] [CrossRef]
  15. Guardia, P.; Labarta, A.; Batlle, X. Tuning the Size, the Shape, and the Magnetic Properties of Iron Oxide Nanoparticles. J. Phys. Chem. C 2011, 115, 390–396. [Google Scholar] [CrossRef]
  16. Bhuiyan, M.S.H.; Miah, M.Y.; Paul, S.C.; Aka, T.D.; Saha, O.; Rahaman, M.M.; Sharif, M.J.I.; Habiba, O.; Ashaduzzaman, M. Green synthesis of iron oxide nanoparticle using Carica papaya leaf extract: Application for photocatalytic degradation of remazol yellow RR dye and antibacterial activity. Heliyon 2020, 6, e04603. [Google Scholar] [CrossRef] [PubMed]
  17. Jasper, R.; Locatelli, G.O.; Pilati, C.; Locatelli, C. Evaluation of biochemical, hematological and oxidative parameters in mice exposed to the herbicide glyphosate-roundup®. Interdiscip. Toxicol. 2012, 5, 133–140. [Google Scholar] [CrossRef]
  18. Gad, S.B.; Zaghloul, D.M. Beneficial effects of green tea extract on liver and kidney functions, ultrastructure, lipid profile and hematological parameters in aged male rats. Glob. Vet. 2013, 11, 191–205. [Google Scholar] [CrossRef]
  19. Wang, D.; Li, H.; Liu, Z.; Zhou, J.; Zhang, T. Acute toxicological effects of zinc oxide nanoparticles in mice after intratracheal instillation. Int. J. Occup. Environ. Health 2017, 23, 11–19. [Google Scholar] [CrossRef]
  20. Gao, L.; Yang, S.T.; Li, S.; Meng, Y.; Wang, H.; Lei, H. Acute toxicity of zinc oxide nanoparticles to the rat olfactory system after intranasal instillation. J. Appl. Toxicol. 2013, 33, 1079–1088. [Google Scholar] [CrossRef]
  21. Chen, J.; Li, C.; Guan, Y.; Kong, Q.; Li, C.; Guo, X.; Chen, Q.; Jing, X.; Lv, Z.; An, Y. Protection of mice from lethal Escherichia coli infection by chimeric human bactericidal/permeability-increasing protein and immunoglobulin G1 Fc gene delivery. Antimicrob. Agents Chemother. 2007, 51, 724–731. [Google Scholar] [CrossRef] [Green Version]
  22. Llobet, J.M.; Domingo, J.L.; Colomina, M.T.; Mayayo, E.; Corbella, J. Subchronic oral toxicity of zinc in rats. Bull. Environ. Contam. Toxicol. 1988, 41, 36–43. [Google Scholar] [CrossRef]
  23. Hunter, P.A.; Rolinson, G.N.; Witting, D.A. Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice. Antimicrob. Agents Chemother. 1973, 4, 285–293. [Google Scholar] [CrossRef] [Green Version]
  24. Al-Qayim, A.J.M.; Ghali, L.; Al-Azwai, T. Comparative effects of propolis and malic acid on hematological parameters of aluminum exposed male rats. Glob. J. Biosci. Biotechnol. 2014, 3, 6–11. [Google Scholar]
  25. Shanker, K.; Mohan, G.K.; Hussain, M.A.M.; Jayarambabu, N.; Pravallika, P.L. Green Biosynthesis, Characterization, In vitro Antidiabetic Activity, and Investigational Acute Toxicity Studies of Some Herbal-mediated Silver Nanoparticles on Animal Models. Phcog. Mag. 2017, 13, 188–192. [Google Scholar] [CrossRef]
  26. Jeng, H.A.; Swanson, J. Toxicity of Metal Oxide Nanoparticles in Mammalian Cells. J. Environ. Sci. Health Part A 2006, 41, 2699–2711. [Google Scholar] [CrossRef]
  27. Akah, P.; Alemji, J. Studies on the effects of Vernonia amygdalina leaf extract and fractions on biochemical and hematological parameters in diabetic rats. Planta Med. 2009, 75. [Google Scholar] [CrossRef]
  28. Rodrigues, J.M.; Fessi, H.; Bories, C.; Puisieux, F.; Devissaguet, J. Primaquine-loaded poly(lactide) nanoparticles: Physicochemical study and acute tolerance in mice. Int. J. Pharm. 1995, 126, 253–260. [Google Scholar] [CrossRef]
  29. Kelly Nitsche, E. Erythrocytosis in Dogs and Cats: Diagnosis and Management. Compend. Contin. Educ. Pract. Vet. 2004, 26, 104–121. [Google Scholar]
  30. Teeguarden, J.G.; Hinderliter, P.M.; Orr, G.; Thrall, B.D.; Pounds, J.G. Particokinetics in vitro: Dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 2007, 95, 300–312. [Google Scholar] [CrossRef] [PubMed]
  31. Hein, M.S. Copper deficiency anemia and nephrosis in zinc-toxicity: A case report. South Dak. J. Med. 2003, 56, 143–147. [Google Scholar]
Figure 1. N2 adsorption-desorption isotherm (inset: XRD pattern) of Fe2O3 NPs.
Figure 1. N2 adsorption-desorption isotherm (inset: XRD pattern) of Fe2O3 NPs.
Toxics 09 00105 g001
Figure 2. SEM (a) and TEM (b) micrographs shows the surface morphology of Fe2O3 NPs.
Figure 2. SEM (a) and TEM (b) micrographs shows the surface morphology of Fe2O3 NPs.
Toxics 09 00105 g002
Figure 3. FTIR spectrum (inset: EDX spectrum) of Fe2O3 NPs.
Figure 3. FTIR spectrum (inset: EDX spectrum) of Fe2O3 NPs.
Toxics 09 00105 g003
Figure 4. Minimum inhibitory concentration of Fe2O3 NPs against S. aureus and E. coli.
Figure 4. Minimum inhibitory concentration of Fe2O3 NPs against S. aureus and E. coli.
Toxics 09 00105 g004
Figure 5. Experimental photographs of in-vitro activity of Fe2O3 NPs against E. coli (a) and S. aureus (b).
Figure 5. Experimental photographs of in-vitro activity of Fe2O3 NPs against E. coli (a) and S. aureus (b).
Toxics 09 00105 g005
Figure 6. The histopathological examination of the kidney, spleen, lung and liver of mice after injecting a low and a high dose of Fe2O3 NPs for 14 days; tolerated dose (14 ppm) and lethal dose (20 ppm).
Figure 6. The histopathological examination of the kidney, spleen, lung and liver of mice after injecting a low and a high dose of Fe2O3 NPs for 14 days; tolerated dose (14 ppm) and lethal dose (20 ppm).
Toxics 09 00105 g006
Figure 7. The histopathological examination of the kidney, spleen, lung and liver of mice after injecting a low and a high dose of S. aureus inoculums for 14 days; (tolerated dose = 3 × 107 CFUs; lethal dose = 4 × 107 CFUs).
Figure 7. The histopathological examination of the kidney, spleen, lung and liver of mice after injecting a low and a high dose of S. aureus inoculums for 14 days; (tolerated dose = 3 × 107 CFUs; lethal dose = 4 × 107 CFUs).
Toxics 09 00105 g007
Figure 8. The histopathological examination of the kidney, spleen, lung and liver of mice after injecting a low and a high dose of E. coli inoculums for 14 days; (tolerated dose = 3 × 107 CFUs; lethal dose = 4 × 107 CFUs).
Figure 8. The histopathological examination of the kidney, spleen, lung and liver of mice after injecting a low and a high dose of E. coli inoculums for 14 days; (tolerated dose = 3 × 107 CFUs; lethal dose = 4 × 107 CFUs).
Toxics 09 00105 g008
Figure 9. The histopathological examination of the kidney, spleen, lung and liver of mice after the simultaneous inoculation of the tolerated concentration of both Fe2O3 NPs (14 ppm) and bacterial suspension (3 × 10−7 CFUs).
Figure 9. The histopathological examination of the kidney, spleen, lung and liver of mice after the simultaneous inoculation of the tolerated concentration of both Fe2O3 NPs (14 ppm) and bacterial suspension (3 × 10−7 CFUs).
Toxics 09 00105 g009
Table 1. Hematological analysis infected and treated mice models.
Table 1. Hematological analysis infected and treated mice models.
ParametersE. coli Infected MiceE. coli-Fe2O3 Inoculated MiceS. aureus Infected MiceS. aureus-Fe2O3 Inoculated MiceNormal Range
WBC13.7 × 109/L1.7 × 109/L8.8 × 109/L2.9 × 109/L0.8–6.8
Lymph #4.2 × 109/L1.2 × 109/L4.7 × 109/L2.3 × 109/L0.7–5.7
Mon #1.2 × 109/L0.1 × 109/L0.6 × 109/L0.1 × 109/L0.0–0.3
Gran #8.4 × 109/L0.4 × 109/L3.5 × 109/L0.5 × 109/L0.1–1.8
Lymph %30.0%71.5%53.0%79.8%55.8–90.6
Mon %8.8%3.0%7.7%3.2%1.8–6.0
Gran %61.1%25.5%39.7%17.0%6.36–9.42
RBC9.24 × 1012/L7.02 × 1012/L8.45 × 1012/L8.61 × 1012/L11.0–14.3
HGB11.1 g/dL10.9 g/dL13.2 g/dL11.8 g/dL8.6–38.9
HCT39.6%37.3%44.9%42.0%34.6–44.0
MCV42.9 fL (L)53.2 fL (L)53.0 fL48.8 fL (L)48.2–58.3
MCH12.0 pg (L)15.5 pg (L)15.5 pg (L)13.7 pg (L)15.8–19.0
MCHC28.0 g/dL (L)29.2 g/dL (L)29.3 g/dL (L)28.0 g/dL (L)30.2–35.3
RDW20.3% (H)17.5% (H)21.1% (H)16.3% (H)13.0–17.0
PLT2599 × 109/L (H)1119 × 109/L (H)1016 × 109/L (H)143 × 109/L (H)450–1690
MPV4.9 fL6.0 fL5.5 fL6.1 fL3.8–6.0
PDW15.716.716.618.2--
PCT--0.6710.558%0.087--
White blood cell (WBC), red blood cell (RBC), red blood cell volume distribution width (RDW), hemoglobin (HGB), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), platelet count (PLT), mean platelet volume (MPV), mononuclear percentage (MOD%), lymphocyte percentage (LYM%) and granulocyte percentage (GRN%). % = percentage, # = counts.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Shah, A.; Tauseef, I.; Ali, M.B.; Yameen, M.A.; Mezni, A.; Hedfi, A.; Haleem, S.K.; Haq, S. In-Vitro and In-Vivo Tolerance and Therapeutic Investigations of Phyto-Fabricated Iron Oxide Nanoparticles against Selected Pathogens. Toxics 2021, 9, 105. https://doi.org/10.3390/toxics9050105

AMA Style

Shah A, Tauseef I, Ali MB, Yameen MA, Mezni A, Hedfi A, Haleem SK, Haq S. In-Vitro and In-Vivo Tolerance and Therapeutic Investigations of Phyto-Fabricated Iron Oxide Nanoparticles against Selected Pathogens. Toxics. 2021; 9(5):105. https://doi.org/10.3390/toxics9050105

Chicago/Turabian Style

Shah, Amreen, Isfahan Tauseef, Manel Ben Ali, Muhammad Arfat Yameen, Amine Mezni, Amor Hedfi, Syed Kashif Haleem, and Sirajul Haq. 2021. "In-Vitro and In-Vivo Tolerance and Therapeutic Investigations of Phyto-Fabricated Iron Oxide Nanoparticles against Selected Pathogens" Toxics 9, no. 5: 105. https://doi.org/10.3390/toxics9050105

APA Style

Shah, A., Tauseef, I., Ali, M. B., Yameen, M. A., Mezni, A., Hedfi, A., Haleem, S. K., & Haq, S. (2021). In-Vitro and In-Vivo Tolerance and Therapeutic Investigations of Phyto-Fabricated Iron Oxide Nanoparticles against Selected Pathogens. Toxics, 9(5), 105. https://doi.org/10.3390/toxics9050105

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop